MedPath

IVERSON GENETIC DIAGNOSTICS, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)

Not Applicable
Suspended
Conditions
DVT
Anti-coagulation Therapy
Atrial Fibrillation
Joint Surgery Multiple
Pulmonary Embolism
Prosthetic Replacement of Mitral Valve
First Posted Date
2011-02-28
Last Posted Date
2015-08-31
Lead Sponsor
Iverson Genetic Diagnostics, Inc.
Target Recruit Count
3800
Registration Number
NCT01305148
Locations
🇺🇸

Veterans' Affairs Medical Center, Birmingham, Alabama, United States

🇺🇸

Cardiovascular Consultants - Thunderbird, Glendale, Arizona, United States

🇺🇸

Cardiovascular Consultants - Phoenix, Phoenix, Arizona, United States

and more 53 locations

News

No news found
© Copyright 2025. All Rights Reserved by MedPath